Farmaseuttinen koostumus käsittäen Sertoli-soluja sekä niiden käyttö

The present invention describes a method of treating a disease that results from a deficiency of a biological factor which includes administering to a mammal Sertoli cells and cells that produce the biological factor. In particular, the present invention describes a method of treating diabetes melli...

Full description

Saved in:
Bibliographic Details
Main Author SELAWRY, HELENA P
Format Patent
LanguageFinnish
Swedish
Published 29.01.2010
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention describes a method of treating a disease that results from a deficiency of a biological factor which includes administering to a mammal Sertoli cells and cells that produce the biological factor. In particular, the present invention describes a method of treating diabetes mellitus by transplanting pancreatic islet of Langerhans cells in conjunction with Sertoli cells to create an immunologically privileged site. A method of creating an immunologically privileged site in a mammal for cellular transplants is further described by the present invention. A pharmaceutical composition comprising Sertoli cells and cells that produce a biological factor is also provided.
AbstractList The present invention describes a method of treating a disease that results from a deficiency of a biological factor which includes administering to a mammal Sertoli cells and cells that produce the biological factor. In particular, the present invention describes a method of treating diabetes mellitus by transplanting pancreatic islet of Langerhans cells in conjunction with Sertoli cells to create an immunologically privileged site. A method of creating an immunologically privileged site in a mammal for cellular transplants is further described by the present invention. A pharmaceutical composition comprising Sertoli cells and cells that produce a biological factor is also provided.
Author SELAWRY, HELENA P
Author_xml – fullname: SELAWRY, HELENA P
BookMark eNrjYmDJy89L5WTwdEssyk0sTi0tKcnMS81TyM7PLy4pzS0tVsg-vKQ4s6Tk8BKgaHBqUUl-TqZucX5OaVaiQnEqUFIhLzMzBaTj8JJKoLJtPAysaYk5xam8UJqbQd7NNcTZQze1ID8-tbggMTk1L7Uk3s3T0MjAzNzAycmYsAoAEmQ55g
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate Farmaceutisk komposition innefattande Sertoli-celler och användning därav
ExternalDocumentID FI120670BB
GroupedDBID EVB
ID FETCH-epo_espacenet_FI120670BB3
IEDL.DBID EVB
IngestDate Fri Jul 19 14:23:52 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Finnish
Swedish
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_FI120670BB3
Notes Application Number: FI19960004033
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20100129&DB=EPODOC&CC=FI&NR=120670B
ParticipantIDs epo_espacenet_FI120670BB
PublicationCentury 2000
PublicationDate 20100129
PublicationDateYYYYMMDD 2010-01-29
PublicationDate_xml – month: 01
  year: 2010
  text: 20100129
  day: 29
PublicationDecade 2010
PublicationYear 2010
RelatedCompanies RESEARCH CORPORATION TECHNOLOGIES, INC
RelatedCompanies_xml – name: RESEARCH CORPORATION TECHNOLOGIES, INC
Score 2.7600095
Snippet The present invention describes a method of treating a disease that results from a deficiency of a biological factor which includes administering to a mammal...
SourceID epo
SourceType Open Access Repository
SubjectTerms BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
Title Farmaseuttinen koostumus käsittäen Sertoli-soluja sekä niiden käyttö
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20100129&DB=EPODOC&locale=&CC=FI&NR=120670B
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSTNOAtW7lrrmySlJoNEqM10LQ9Mk3STjxNQU07QUozRD0OZkXz8zj1ATrwjTCCaGdNheGPA5oeXgwxGBOSoZmN9LwOV1AWIQywW8trJYPykTKJRv7xZi66IG7R0bgsdV1FycbF0D_F38ndWcnW3dPNX8gmwNQceUGzgxM7AC29DmoKzgGuYE2pJSgFyfuAkysAUAjcorEWJgSssUZuB0hl27JszA4Qud7QYyoRmvWITB0w009FycWgpappyap5Cdn19cUppbWqyQfXhJcWZJyeElQFFgxi_Jz8nUBaWnrESF4lSgpEJeJujeUJC6SqCybaIM8m6uIc4eukA3xcN9H-_mCXW7k7EYA0tefl6qBIOCcapJqnmKMeg8NmCVnAKs143SQIfTARtrySnJJoaSDBK4TJHCLSXNwAWZHDfUNbKUYWApKSpNlQXWuSVJcuDwAgA8Hotg
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSTNOAtW7lrrmySlJoNEqM10LQ9Mk3STjxNQU07QUozRD0OZkXz8zj1ATrwjTCCaGdNheGPA5oeXgwxGBOSoZmN9LwOV1AWIQywW8trJYPykTKJRv7xZi66IG7R0bgsdV1FycbF0D_F38ndWcnW3dPNX8gmwNQceUGzgxM7AC29fmoKzgGuYE2pJSgFyfuAkysAUAjcorEWJgSssUZuB0hl27JszA4Qud7QYyoRmvWITB0w009FycWgpappyap5Cdn19cUppbWqyQfXhJcWZJyeElQFFgxi_Jz8nUBaWnrESF4lSgpEJeJujeUJC6SqCybaIM8m6uIc4eukA3xcN9H-_mCXW7k7EYA0tefl6qBIOCcapJqnmKMeg8NmCVnAKs143SQIfTARtrySnJJoaSDBK4TJHCLSXPwOkR4usT7-Pp5y3NwAWZKDfUNbKUYWApKSpNlQXWvyVJcuCwAwDxQo5T
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Farmaseuttinen+koostumus+k%C3%A4sitt%C3%A4en+Sertoli-soluja+sek%C3%A4+niiden+k%C3%A4ytt%C3%B6&rft.inventor=SELAWRY%2C+HELENA+P&rft.date=2010-01-29&rft.externalDBID=B&rft.externalDocID=FI120670BB